The ProteinChip ® Biomarker System from Ciphergen Biosystems:: a novel proteomics platform for rapid biomarker discovery and validation

被引:39
作者
Chapman, K [1 ]
机构
[1] Ciphergen Biosyst Ltd, Surrey Technol Ctr, Guildford GU2 7YG, Surrey, England
关键词
biomarker; mass spectrometry; protein biochip; proteomics; SELDI;
D O I
10.1042/BST0300082
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Protein biochips are emerging in two distinct formats. The first involves high-density immobilized arrays of recognition molecules (e.g. antibodies), where target binding is monitored indirectly (e.g. via fluorescence). This technology is in its infancy, being limited by the availability of suitable binding molecules that can cope effectively with protein diversity. The second format involves the capture of proteins by biochemical or intermolecular interaction, coupled with direct detection by MS. This technology is available as the ProteinChip(R) Biomarker System. ProteinChip technology uses surface-enhanced laser desorption/ionization processes to analyse proteins directly from biological samples. Chromatographic surfaces are placed on to ProteinChip Arrays and used to capture subclasses of proteins, dependent on their physical properties. Time-of-flight MS then assigns native molecular masses to the captured proteins. Reproducible protein profiles can be generated from crude biological fluids (e.g. cell lysates, urine or serum). The technology is being applied to a,vide range of disciplines, from plant sciences to cancer research, and will be reviewed here.
引用
收藏
页码:82 / 87
页数:6
相关论文
共 16 条
  • [1] Andersen Alan N., 1997, Conservation Ecology, V1, pUnpaginated
  • [2] ENGLERT CR, 1999, CURR OPIN MOL THER, V2, P264
  • [3] Fung ET, 2000, CURR OPIN MOL THER, V2, P643
  • [4] Markers of bladder cancer State of the art
    Grossman, HB
    Dinney, CPN
    [J]. UROLOGIC ONCOLOGY, 2000, 5 (01): : 3 - 10
  • [5] Jenkins RE, 2001, PROTEOMICS, V1, P13, DOI 10.1002/1615-9861(200101)1:1<13::AID-PROT13>3.3.CO
  • [6] 2-A
  • [7] Johnston-Wilson NL, 2001, INT J NEUROPSYCHOPH, V4, P83, DOI 10.1017/S1461145701002255
  • [8] Merchant M, 2000, ELECTROPHORESIS, V21, P1164, DOI 10.1002/(SICI)1522-2683(20000401)21:6<1164::AID-ELPS1164>3.3.CO
  • [9] 2-S
  • [10] Paweletz CP, 2000, DRUG DEVELOP RES, V49, P34, DOI 10.1002/(SICI)1098-2299(200001)49:1<34::AID-DDR6>3.0.CO